E-LIB Suche - Ergebnisse für: Fueyo, J.

1

P17.14.B PHASE I TRIAL OF DNX-2401 ONCOLYTIC ADENOVIRUS COM..:

Gallego Perez-Larraya, J ; García-Moure, M ; González-Huárriz, M...
Neuro-Oncology. 25 (2023) Supplement_2 - p. ii120-ii120 , 2023

Link: https://doi.org/10.1093/..

2

P17.15.A THANK PHASE I TRIAL OF DNX-2440 ONCOLYTIC ADENOVIR..:

Gallego Perez-Larraya, J ; de la Nava, D ; González-Huárriz, M...
Neuro-Oncology. 25 (2023) Supplement_2 - p. ii120-ii120 , 2023

Link: https://doi.org/10.1093/..

3

Almost never you get what you pay for: Widespread mislabeli..:

Parrondo, M. ; López, S. ; Aparicio-Valencia, A....
Food Control. 120 (2021) - p. 107541 , 2021

Link: https://doi.org/10.1016/..

4

Closing of large pharyngostomes with free flaps and proposa..:

Llorente, J. L. ; Sánchez, P. ; López, F....
European Archives of Oto-Rhino-Laryngology. 277 (2020) 11 - p. 3137-3144 , 2020

Link: https://doi.org/10.1007/..

5

Correction: The anti-metastatic activity of collagenase-2 i..:

Soria-Valles, C ; Gutiérrez-Fernández, A ; Guiu, M...
Oncogene. 38 (2019) 28 - p. 5739-5739 , 2019

Link: https://doi.org/10.1038/..

6

OS5.1 Phase I clinical trial with oncolytic virus DNX-2401 ..:

Alonso, M M ; Iñigo, I ; Gonzalez-Huarriz, M...
Neuro-Oncology. 21 (2019) Supplement_3 - p. iii11-iii11 , 2019

Link: https://doi.org/10.1093/..

7

P06.01 Delta24-ACT oncolytic adenovirus as a therapeutic ap..:

Laspidea, V ; Puigdelloses, M ; García-Moure, M...
Neuro-Oncology. 21 (2019) Supplement_3 - p. iii36-iii36 , 2019

Link: https://doi.org/10.1093/..

8

IM-04 * DELTA-24-RDG AS AN ALTERNATIVE THERAPEUTIC TOOL FOR..:

Martinez-Velez, N. ; Xipell, E. ; Jiang, H....
Neuro-Oncology. 17 (2015) suppl 3 - p. iii15-iii15 , 2015

Link: https://doi.org/10.1093/..

9

PRESENCE OF A DISTINCTIVE MYELOID POPULATION IS ASSOCIATED ..:

Gomez-Manzano, C. ; Gabrusiewicz, K. ; Cortes-Santiago, N....
Neuro-Oncology. 16 (2014) suppl 3 - p. iii15-iii15 , 2014

Link: https://doi.org/10.1093/..

10

Intratumoral heterogeneity and intraclonal plasticity: from..:

Conrad, C. A. ; Fueyo, J. ; Gomez-Manzano, C.
Neuro-Oncology. 16 (2014) 8 - p. 1025-1026 , 2014

Link: https://doi.org/10.1093/..

11

ME-05 * COUNTERATTACKING THE FORCE BEHIND GLIOMA INVASION:

Cortes-Santiago, N. ; Hossain, M. B. ; Gabrusiewicz, K....
Neuro-Oncology. 16 (2014) suppl 5 - p. v120-v120 , 2014

Link: https://doi.org/10.1093/..

12

NT-18 * PHASE I CLINICAL TRIAL OF ONCOLYTIC VIRUS DELTA-24-..:

Lang, F. F. ; Conrad, C. ; Gomez-Manzano, C....
Neuro-Oncology. 16 (2014) suppl 5 - p. v162-v162 , 2014

Link: https://doi.org/10.1093/..

13

ET-66 * ER-STRESS INDUCING DRUGS SENSITIZES GBM TO TEMOZOLO..:

Xipell, E. ; Martinez-Velez, N. ; Vera-Cano, B....
Neuro-Oncology. 16 (2014) suppl 5 - p. v93-v93 , 2014

Link: https://doi.org/10.1093/..

14

NEW GLIOMA-ASSOCIATED AUTO-ANTIBODIES:

Fueyo, J. ; Conrad, C. ; Gomez-Manzano, C....
Neuro-Oncology. 16 (2014) suppl 3 - p. iii41-iii41 , 2014

Link: https://doi.org/10.1093/..

15

FIRST-IN-HUMAN PHASE I CLINICAL TRIAL OF ONCOLYTIC DELTA-24..:

Lang, F. F. ; Conrad, C. ; Gomez-Manzano, C....
Neuro-Oncology. 16 (2014) suppl 3 - p. iii39-iii39 , 2014

Link: https://doi.org/10.1093/..